Locations
Company type
Result types
Industries
Employees
Founding year
The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
IRBM SPA
Pomezia, Italy
B
101-250 Employees
2009
Key takeaway
IRBM is a prominent research organization specializing in advanced drug discovery, highlighting its expertise in transforming early-stage science into effective therapeutics. The company employs innovative approaches across various areas, including antibody and peptide drug discovery, structural biology, and computational sciences, ensuring a comprehensive pathway from research to market.
Reference
Service
Capabilities - IRBM
27 January 2019 - Capabilities -
APhaD Srl
Buccinasco, Italy
B
1-10 Employees
2013
Key takeaway
APhaD is a specialized Contract Research Organization (CRO) that offers tailored services for pharmaceutical projects, including early ADMET, formulations, and bio-analysis. Their experienced team ensures high-quality data and solutions throughout the drug discovery process, from initial discovery programs to clinical phases.
Reference
Core business
About us - Aphad - Analytical solution
To provide tailored solutions for early ADMET, formulations, analysis and bio-analysis in drug development.
Alvascience
Italy
B
1-10 Employees
2018
Key takeaway
Alvascience, founded in 2018, enhances cheminformatics research through advanced software solutions that leverage machine learning and innovative technologies. Their tool, alvaDesc, efficiently calculates molecular descriptors and properties, benefiting researchers in pharmacology and related fields by streamlining the drug discovery process.
Reference
Core business
Software Solutions for Chemoinformatics and QSAR - Alvascience
Software Solutions for Chemoinformatics and QSAR
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Advice Pharma Group S.R.L.
Milan, Italy
B
11-50 Employees
-
Key takeaway
AdvicePharma is an Italian company that develops services and technologies for managing data and information in the medical and scientific field.
Reference
Product
Technologies - AdvicePharma
InSilicoTrials Technologies
Trieste, Italy
B
11-50 Employees
2016
Key takeaway
InSilicoTrials is revolutionizing drug development by leveraging artificial intelligence and computational models to accelerate the R&D process, significantly reducing costs and time associated with clinical trials. Their commitment to innovative, cloud-based solutions aligns with the goal of enhancing access to affordable medicines and improving safety through advanced modeling and simulation techniques.
Reference
Core business
InSilicoTrials - Modeling and simulation in drug development
Cutting-edge insilico modeling and simulation technology made simple and cost-effective. Modeling and simulation in drug development
Neuro-Zone
Bresso, Italy
B
1-10 Employees
2007
Key takeaway
Neuro-Zone is a functional service company that supports drug discovery and preclinical research, particularly in age-related pathologies and inflammation. They offer a range of services from screening chemical libraries to validating candidate compounds, utilizing advanced cell-based platforms for multiparametric analysis.
Reference
Core business
Neuro-Zone - functional solutions for drug discovery
InnovaVector
Pozzuoli, Italy
B
11-50 Employees
2019
Key takeaway
InnovaVector specializes in the development and production of Adeno-Associated Viral (AAV) vectors for both non-clinical and clinical use, which is crucial for advancing gene therapies. Their expertise and commitment to high-quality AAV production support the growing demand in the field of gene therapy research and development.
Reference
Product
Discovery Research Service - Innovavector
NMS Group
Nerviano, Italy
B
251-500 Employees
2012
Key takeaway
Nerviano Medical Sciences is actively developing a proprietary platform for creating novel Antibody-Drug Conjugates (ADCs) and leveraging its core Discovery engine to generate new molecular entities with potential for "first in class" and "best in class" oncology drugs. The company's innovative research and commitment to clinical development aim to accelerate the delivery of personalized medicines to cancer patients.
Reference
Core business
Homepage - Nerviano Medical Sciences
Adam AI Solutions
Milan, Italy
B
1-10 Employees
2019
Key takeaway
The company emphasizes its commitment to utilizing data to enhance safety and prevent workplace incidents. Their expertise in incident dynamics and innovative strategies may be relevant to advancing AI applications in drug discovery.
Reference
Product
discovery | Adam AI Solutions
Adamas Biotech Srl
Maglie, Italy
B
1-10 Employees
-
Key takeaway
Adamas Biotech focuses on developing clinically validated, nutraceutical-based solutions aimed at enhancing health and well-being. Their commitment to evidence-based medicine and innovative, scientifically validated products may align with advancements in health-related research and discovery.
Reference
Core business
Adamas Biotech - Homepage
More than a decade of basic research in the field of botanical function-specific antioxidants. The nutraceutical solutions proposed to stem from a patented protected technology.
Technologies which have been searched by others and may be interesting for you:
When exploring the AI drug discovery industry in Italy, several key factors should be considered. The regulatory landscape is crucial, as compliance with both European and Italian regulations impacts the development and approval of new drugs. Italy has a strong emphasis on innovation, supported by government initiatives and funding for research and development, making it an attractive environment for AI-driven companies. Challenges include navigating complex intellectual property rights and the need for collaboration between tech firms and traditional pharmaceutical companies. The competitive landscape is evolving, with both startups and established players vying for market share, leading to a dynamic ecosystem. Opportunities in this sector are significant, particularly in leveraging AI to streamline drug development processes and reduce costs, which is increasingly relevant in a post-pandemic world where rapid drug development is critical. Environmental concerns also come into play, as sustainable practices are becoming more important in drug manufacturing and discovery. Global market relevance is heightened by Italy's strategic position within Europe, providing access to a larger market and facilitating partnerships with international firms. Understanding these aspects can provide valuable insights for anyone looking to engage with the AI drug discovery industry in Italy.
Some interesting numbers and facts about your company results for Ai Drug Discovery
| Country with most fitting companies | Italy |
| Amount of fitting manufacturers | 208 |
| Amount of suitable service providers | 167 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 2007 |
| Youngest suiting company | 2019 |
Some interesting questions that has been asked about the results you have just received for Ai Drug Discovery
What are related technologies to Ai Drug Discovery?
Based on our calculations related technologies to Ai Drug Discovery are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Which industries are mostly working on Ai Drug Discovery?
The most represented industries which are working in Ai Drug Discovery are IT, Software and Services, Other, Biotechnology, Pharmaceuticals, Medical
How does ensun find these Ai Drug Discovery Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.